OpenAlex
PricingAboutJobs
Log inGet started
Work

Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study

HTML

Year: 2008
Type: article
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2008.16.3758
Authors: Hansjochen Wilke, Robert Glynne-Jones, Josef Thaler, Antoine Adenis, Peter Preusser, Enrique Aranda Aguilar, Matti S. Aapro, Regina Esser, Anja H. Loos, Salvatore Siena
Institutions: Merck KGaA, Darmstadt (Germany), University of Münster, Mount Vernon Hospital, Clinique de Genolier, Mount Vernon Cancer Centre, Barmherzige Schwestern vom heiligen Kreuz, Hospital Universitario Reina Sofía, Centre Oscar Lambret, Kliniken Essen-Mitte
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cetuximab, irinotecan, metastatic colorectal cancer, irinotecan-refractory disease, progression-free survival, treatment safety, infusion reactions
SDG: Good health and well-being

Open Access status: closed

Funder: Merck KGaA
OpenAlex ID: W2164055979
FWCI: 6.374
Cites: 26
Cited by: 111
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security